Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label tamsulosin study in children with neuropathic bladder
2006-004423-11Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tamsulosin in neurogenic bladder (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Primary efficacy endpoint. Started Sep 2006; status: completed.
02
Drugs
tamsulosin
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on 2006-004423-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004423-11.